Datametrex Enters Strategic Agreement with Hilco Global to Advance Patent Monetization

Datametrex AI Limited’s wholly‑owned subsidiary Paymetrex Payment Solutions Inc. signed a strategic agreement with Hilco Global’s IP Services Practice on March 23, 2026 (announced April 8, 2026). Hilco will evaluate, value and execute licensing, auction or direct sale opportunities for Paymetrex’s SoftPOS and mobile‑payment patents using AI‑driven analytics. The engagement is intended to create a structured, data‑centric licensing program that can generate royalty streams from the growing software‑based point‑of‑sale market.

• Scope vs prior announcements: Earlier in 2026 Datametrex announced (i) a royalty‑bearing license with AnywhereCommerce and (ii) the launch of its own patent‑licensing program, followed by a partnership with Pelent AI for licensing analytics. The Hilco agreement is an additional execution partner, not a new revenue contract.
• Revenue generation: No immediate cash or royalty receipts are disclosed; the impact will be realized only as licenses or sales are completed, which could take months to years.
• Market perception: Adding a reputable IP‑monetization specialist (Hilco) may improve investor confidence in the company’s ability to extract value from its patent portfolio, but the market has already priced in the strategic direction.
• Materiality judgment: The news is positive because it advances an existing monetisation strategy, yet it does not introduce a material financial change or surprise. It therefore fits the “Routine – Positive” category.

Datametrex AI Limited develops AI‑enabled solutions across payments, healthcare EMR, and data‑centre infrastructure. Its flagship IP asset is the Paymetrex patent portfolio covering SoftPOS, mobile payment authorization and related technologies (10 granted patents from Yuzu acquisition). The company seeks to monetize these patents through licensing, royalties and possible sales.